Nevada Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nevada Tech Journal.

Press releases published on August 28, 2026

12 hours ago

Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million

Indeterminate GlobeNewswire

12 hours ago

Jiayin Group Inc. Reports Second Quarter 2026 Unaudited Financial Results

Indeterminate GlobeNewswire

13 hours ago

CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio

Indeterminate GlobeNewswire

15 hours ago

STARCARES Completes Basketball Court Revamp in the Philippines, Benefiting Nearly 20,000 People

Indeterminate GlobeNewswire

15 hours ago

Chiesi Global Rare Diseases Demonstrates Its Ongoing Commitment to the Rare Disease Community at the Society of Inborn Errors of Metabolism (SSIEM) 2026 Annual Symposium

Indeterminate GlobeNewswire

15 hours ago

Chiesi Global Rare Diseases Demonstrates Its Ongoing Commitment to the Rare Disease Community at the Society of Inborn Errors of Metabolism (SSIEM) 2026 Annual Symposium

Indeterminate GlobeNewswire

15 hours ago

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

Indeterminate GlobeNewswire

16 hours ago

Micware Group Reorganization Finalized

Indeterminate GlobeNewswire

17 hours ago

OSE Immunotherapeutics organisera un webcast dédié à lusvertikimab avec des leaders d’opinion le 2 septembre 2026

Indeterminate GlobeNewswire

17 hours ago

OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026

Indeterminate GlobeNewswire

Aug. 28, 2026

StoreClaw Concludes Participation at MDS Singapore Summit 2026

Indeterminate GlobeNewswire

Aug. 28, 2026

Snail Games 于 Gamescom 2026 游戏展上蓄势待发：IP 拓展、内部研发与新作前瞻

Indeterminate GlobeNewswire

Aug. 28, 2026

Snail Games 在 Gamescom 2026 上重點展示 IP 擴展、內部開發及矚目新作

Indeterminate GlobeNewswire

Aug. 28, 2026

Splashtop and SOURCENEXT Partner to Offer Splashtop Shield in Japan

Indeterminate GlobeNewswire

Aug. 28, 2026

HUTCHMED Announces NMPA Approval for ATLED® (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma

Indeterminate GlobeNewswire